What is Breaking?
Breaking is a pioneering company in the field of plastic degradation and synthetic biology. Gestated at Colossal Biosciences, its foundation is built upon a core discovery originating from the Wyss Institute for Biologically Inspired Engineering at Harvard University. The company aims to leverage advanced biological engineering to address the persistent global issue of plastic waste, positioning itself at the forefront of environmental biotechnology.
How much funding has Breaking raised?
Breaking has raised a total of $10.5M across 1 funding round:
Angel/Seed
$10.5M
Angel/Seed (2024): $10.5M, investors not publicly disclosed
What's next for Breaking?
With a major enterprise-level funding context and a recent strategic investment, Breaking is poised for significant scaling and further research and development. This backing will likely accelerate the company's efforts to commercialize its plastic-degrading technologies and expand its synthetic biology applications. The focus will probably be on optimizing its biological processes, potentially forging strategic partnerships for large-scale deployment, and further solidifying its position as a leader in the environmental solutions sector.
See full Breaking company page
